EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021

Jing Xie, Jian-She Xu, Jiang-Wei Huang, Yi-Shan Zheng

Frontiers in Pediatrics · 26.06.2025 · 13

DOI: 10.3389/fped.2025.1618810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 26.06.2025. Verfasst von Jing Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood non-Hodgkin lymphoma (NHL) is a significant contributor to pediatric cancer morbidity and mortality worldwide. This study aims to assess the global, regional, and national burden of childhood NHL from 1990 to 2021, using data from the Global Burden of Disease (GBD) 2021 study.

Methods

Incidence, mortality, and disability-adjusted life years (DALYs) related to childhood NHL were analyzed across 204 countries and 21 geographic regions using standardized methods from the GBD 2021 study. Estimated annual percentage change (EAPC) and average annual percentage change (AAPC) were calculated to evaluate long-term trends. Frontier and inequality analyses were applied to assess the relationship between sociodemographic development and disease burden.

Results

In 2021, there were 20,788.76 (95% uncertainty intervals, UI: 17,199.49–25,305.83) new childhood NHL cases globally, with an incidence rate of 1.03 per 100,000 (95% UI: 0.85–1.26). The global mortality rate decreased from 0.75 (95% UI: 0.57–0.89) in 1990 to 0.45 (95% UI: 0.36–0.56) in 2021 (EAPC: −1.49, 95% confidence interval, CI: −1.60 to −1.39). DALYs rates also declined from 63.38 (95% UI: 48.09–75.72) in 1990 to 37.83 (95% UI: 29.95–47.17) in 2021 (EAPC: −1.51, 95% CI: −1.61 to −1.40). Burden reductions were most significant in high-SDI regions. In contrast, several low- and middle-SDI regions, particularly in Sub-Saharan Africa, experienced either slow declines or rising burden, with Southern Sub-Saharan Africa showing the largest increase in DALYs rate.

Conclusions

While advancements in treatment and healthcare infrastructure have contributed to declining childhood NHL mortality, persistent disparities highlight the need for targeted interventions in low-SDI regions. Strengthening pediatric oncology capacity, expanding treatment accessibility, and enhancing early detection efforts are crucial for reducing global inequalities in childhood NHL outcomes.

Schlagwörter

Stichwörter der Autor:innen

childhood non-Hodgkin lymphomadisability-adjusted life years (DALYs)health disparitiesincidencemortality

Autor:innen und Institutionen

  • Department of Intensive Care Unit, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
  • School of Public Health, Nanjing Medical University, Nanjing, China.

Zitieren

APA

Xie, J., Xu, J. S., Huang, J. W., & Zheng, Y. S. (2025). Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021. Frontiers in Pediatrics, 13. https://doi.org/10.3389/fped.2025.1618810

Vancouver

Xie J, Xu JS, Huang JW, Zheng YS. Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021. Frontiers in Pediatrics. 2025;13. doi:10.3389/fped.2025.1618810

BibTeX
@article{Xie2025,
  author = {Xie, Jing and Xu, Jian-She and Huang, Jiang-Wei and Zheng, Yi-Shan},
  title = {Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021},
  journal = {Frontiers in Pediatrics},
  year = {2025},
  volume = {13},
  doi = {10.3389/fped.2025.1618810}
}
Kostenlos starten →